Technical Analysis for IQV - IQVIA Holdings, Inc.

Grade Last Price % Change Price Change
D 219.09 -1.51% -3.36
IQV closed down 1.51 percent on Friday, May 31, 2024, on 3.81 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
5 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
180 Bearish Setup Bearish Swing Setup -1.51%
Stochastic Reached Oversold Weakness -1.51%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

IQVIA Holdings, Inc. Description

IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: S&P 500 Life Sciences Technology Solutions Project Management Healthcare Service Biopharmaceutical Development Q2 Technology Enabled Healthcare Services

Is IQV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 261.73
52 Week Low 167.42
Average Volume 918,968
200-Day Moving Average 221.06
50-Day Moving Average 234.72
20-Day Moving Average 228.31
10-Day Moving Average 226.66
Average True Range 4.90
RSI (14) 34.64
ADX 19.57
+DI 13.11
-DI 31.47
Chandelier Exit (Long, 3 ATRs) 222.87
Chandelier Exit (Short, 3 ATRs) 231.34
Upper Bollinger Bands 236.02
Lower Bollinger Band 220.60
Percent B (%b) -0.1
BandWidth 6.75
MACD Line -2.96
MACD Signal Line -2.28
MACD Histogram -0.6807
Fundamentals Value
Market Cap 39.98 Billion
Num Shares 183 Million
EPS 5.96
Price-to-Earnings (P/E) Ratio 36.76
Price-to-Sales 2.68
Price-to-Book 6.86
PEG Ratio 1.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 229.44
Resistance 3 (R3) 229.78 226.66 227.72
Resistance 2 (R2) 226.66 224.03 226.50 227.14
Resistance 1 (R1) 222.88 222.40 221.32 222.54 226.56
Pivot Point 219.76 219.76 218.99 219.60 219.76
Support 1 (S1) 215.98 217.13 214.42 215.64 211.62
Support 2 (S2) 212.86 215.50 212.70 211.04
Support 3 (S3) 209.08 212.86 210.47
Support 4 (S4) 208.74